Cargando…

Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis

Background. Amphotericin-based combination antifungal therapy reduces mortality from human immunodeficiency virus (HIV)-associated cryptococcal meningitis. However, 40%–50% of individuals have positive cerebrospinal fluid (CSF) fungal cultures at completion of 2 weeks of amphotericin induction thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rolfes, Melissa A., Rhein, Joshua, Schutz, Charlotte, Taseera, Kabanda, Nabeta, Henry W., Huppler Hullsiek, Kathy, Akampuira, Andrew, Rajasingham, Radha, Musubire, Abdu, Williams, Darlisha A., Thienemann, Friedrich, Bohjanen, Paul R., Muzoora, Conrad, Meintjes, Graeme, Meya, David B., Boulware, David R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Major Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4692307/ https://www.ncbi.nlm.nih.gov/pubmed/26716103 http://dx.doi.org/10.1093/ofid/ofv157

Ejemplares similares

The Effect of Therapeutic Lumbar Punctures on Acute Mortality From Cryptococcal Meningitis
por: Rolfes, Melissa A., et al.
Publicado: (2014)

Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis
por: Schutz, Charlotte, et al.
Publicado: (2017)

Blood neutrophil counts in HIV-infected patients with cryptococcal meningitis: Association with mortality
por: Musubire, Abdu Kisekka, et al.
Publicado: (2018)

Correlation between Blood and CSF Compartment Cytokines and Chemokines in Subjects with Cryptococcal Meningitis
por: Okafor, Elizabeth C., et al.
Publicado: (2020)

Evolving Failures in the Delivery of Human Immunodeficiency Virus Care: Lessons From a Ugandan Meningitis Cohort 2006–2016
por: Flynn, Andrew G., et al.
Publicado: (2017)

Human Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding
por: Boulware, David R., et al.
Publicado: (2015)

Standardized Electrolyte Supplementation and Fluid Management Improves Survival During Amphotericin Therapy for Cryptococcal Meningitis in Resource-Limited Settings
por: Bahr, Nathan C., et al.
Publicado: (2014)

Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial
por: Scriven, James E., et al.
Publicado: (2015)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

Multisite Validation of Cryptococcal Antigen Lateral Flow Assay and Quantification by Laser Thermal Contrast
por: Boulware, David R., et al.
Publicado: (2014)

Sterile Cerebrospinal Fluid Culture at Cryptococcal Meningitis Diagnosis Is Associated with High Mortality
por: Skipper, Caleb P, et al.
Publicado: (2022)

Management of amphotericin-induced phlebitis among HIV patients with cryptococcal meningitis in a resource-limited setting: a prospective cohort study
por: Ahimbisibwe, Cynthia, et al.
Publicado: (2019)

1472 Epidemiology of Meningitis in an HIV-infected Ugandan Cohort
por: Rajasingham, Radha, et al.
Publicado: (2014)

Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa
por: Rajasingham, Radha, et al.
Publicado: (2014)

869. Oral Encochleated Amphotericin B for Cryptococcal Meningitis: a Phase II Randomized Trial
por: Atukunda, Mucunguzi, et al.
Publicado: (2022)

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2020)

Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort
por: Tugume, Lillian, et al.
Publicado: (2022)

Transcriptomic biomarker pathways associated with death in HIV-infected patients with cryptococcal meningitis
por: Vlasova-St Louis, Irina, et al.
Publicado: (2021)

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts
por: Montgomery, Martha P., et al.
Publicado: (2017)

1716. Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis
por: Chesdachai, Supavit, et al.
Publicado: (2019)

Efficacy of Adjunctive Sertraline for the Treatment of HIV-Associated Cryptococcal Meningitis: an open-label dose-ranging study
por: Rhein, Joshua, et al.
Publicado: (2016)

Detrimental Outcomes of Unmasking Cryptococcal Meningitis With Recent ART Initiation
por: Rhein, Joshua, et al.
Publicado: (2018)

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?
por: Kagimu, Enock, et al.
Publicado: (2022)

Cerebral Oximetry for Detecting High-mortality Risk Patients with Cryptococcal Meningitis
por: Diehl, John W, et al.
Publicado: (2018)

Gastrointestinal cryptococcoma – Immune reconstitution inflammatory syndrome or cryptococcal relapse in a patient with AIDS?
por: Musubire, Abdu K., et al.
Publicado: (2015)

Evaluation of a point-of-care immunoassay test kit ‘StrongStep’ for cryptococcal antigen detection
por: Mpoza, Edward, et al.
Publicado: (2018)

Hearing Loss in Cryptococcal Meningitis Survivors
por: Lofgren, Sarah, et al.
Publicado: (2017)

Cryptococcal Meningitis Treatment Strategies in Resource-Limited Settings: A Cost-Effectiveness Analysis
por: Rajasingham, Radha, et al.
Publicado: (2012)

Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study
por: Boulware, David R., et al.
Publicado: (2010)

Tuberculosis in HIV-Associated Cryptococcal Meningitis is Associated with an Increased Risk of Death
por: Rutakingirwa, Morris K., et al.
Publicado: (2020)

1468 Detection of High CSF Levels of (1 → 3)-Beta-D-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

1791 Evaluating Cryptococcal Antigen Lateral Flow Assay by Fingerstick Whole Blood in HIV-Infected Persons with Meningitis
por: Williams, Darlisha, et al.
Publicado: (2014)

A qualitative evaluation of an implementation study for cryptococcal antigen screening and treatment in Uganda
por: Lofgren, Sarah M., et al.
Publicado: (2018)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis
por: Rhein, Joshua, et al.
Publicado: (2014)

Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100
por: Kwizera, Richard, et al.
Publicado: (2014)

Cryptococcal Disease in the Era of “Test and Treat”: Is There Cause for Concern?
por: Abassi, Mahsa, et al.
Publicado: (2017)

Evaluation of Fingerstick Cryptococcal Antigen Lateral Flow Assay in HIV-Infected Persons: A Diagnostic Accuracy Study
por: Williams, Darlisha A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pe9t9u5fdct69depqpeevqsg8q